Last 67.75 INR
Change Today +1.15 / 1.73%
Volume 2.3K
As of 7:06 AM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

themis medicare ltd (TMCH) Snapshot

Open
68.00
Previous Close
66.60
Day High
68.70
Day Low
67.00
52 Week High
11/13/12 - 120.60
52 Week Low
03/22/13 - 49.00
Market Cap
545.4M
Average Volume 10 Days
1.1K
EPS TTM
-5.93
Shares Outstanding
8.1M
EX-Date
07/20/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for THEMIS MEDICARE LTD (TMCH)

Related News

No related news articles were found.

themis medicare ltd (TMCH) Related Businessweek News

No Related Businessweek News Found

themis medicare ltd (TMCH) Details

Themis Medicare Limited manufactures and markets pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients; and formulations in dosage forms in the areas of anti tuberculosis, anti malarial, anesthetics, anti infective, anti hemorrhoid, pain management, anti osteoporotic, nutritional supplement, and haemostatic agents. It also provides generics, including oral solids and liquids, injectables, and topical preparations. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1969 and is headquartered in Mumbai, India.

Founded in 1969

themis medicare ltd (TMCH) Top Compensated Officers

Managing Director, Chief Executive Officer, M...
Total Annual Compensation: 5.6M
Deputy Managing Director, Member of Executive...
Total Annual Compensation: 5.4M
Compensation as of Fiscal Year 2012.

themis medicare ltd (TMCH) Key Developments

Themis Medicare Ltd to Report Fiscal Year 2013 Results on May 15, 2013

Themis Medicare Ltd announced that they will report fiscal year 2013 results on May 15, 2013

Themis Medicare Ltd, Board Meeting, May 15, 2013

Themis Medicare Ltd, Board Meeting, May 15, 2013. Agenda: To consider the audited financial results for the year ended March 31, 2013.

Themis Medicare Enters into a License and Supply Agreement with Novartis India

Themis Medicare Ltd. enetered into a License and Supply Agreement with Novartis India. As per agreement, the company has agreed to manufacture and supply Diclofenac topical gel to Novartis.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMCH:IN 67.75 INR +1.15

TMCH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TMCH.
View Industry Companies
 

Industry Analysis

TMCH

Industry Average

Valuation TMCH Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THEMIS MEDICARE LTD, please visit www.themismedicare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.